* Amgen receives positive CHMP opinion to extend indication
of Kyprolis (carfilzomib) for the treatment of relapsed
multiple myeloma
The post BRIEF-Amgen receives positive CHMP opinion to extend indication of Kyprolis appeared first on NASDAQ.
BRIEF-Amgen receives positive CHMP opinion to extend indication of Kyprolis
